Tevra Brands drops US antitrust claims against Elanco
( October 14, 2026, 03:59 GMT | Official Statement) -- MLex Summary: Tevra Brands has dropped its US antitrust claims accusing Elanco Animal Health of illegally maintaining a monopoly over the market for imidacloprid topicals for dogs and cats, according to an order signed by US District Judge Beth Freeman dismissing the claims with prejudice.See attached file....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.